SN STOCK ANALYSIS

Smith & Nephew PLC — price, returns and risk statistics

SNSmith & Nephew PLC

🇬🇧 UK · LSE · Healthcare · Medical Devices

Value itDuel

Price summary

Last Close

1,127.00 $

Jul 3, 26

Market Cap

13.1 B $

Q2 2025 (TTM)

52-Week Range

1,071.16 $1,401.83 $

Return and risk cards

Total Return

%+4.2

Trailing 1-year performance

Volatility

%28.3

Price fluctuation measure

Sharpe Ratio

-1.13

Risk/Return ratio

Sortino Ratio

-1.20

Downside risk/return

Distance to Peak

%-19.6

Difference from 52-week peak

Maximum Drawdown

-%23.4

Deepest 1-year decline

Seasonality

Seasonality Chart

Year 2023
Year 2024
Year 2025
Current Period 2026
3/3 positive months

Periodic Returns

1M

+1.7%

3M

-6.7%

6M

-6.0%

YTD

-7.6%

1Y

+4.2%

3Y

+1.7%

Returns are computed from split-adjusted closes; dividends are not included.

YTD Return — Stock vs Asset Classes

Year-to-date
SN-7.6%Gold-3.8%Silver-11.3%FTSE 100+7.5%

Stock and gold/silver returns are in USD (metals converted into the stock's currency). The FTSE 100 index is measured in its own currency.

Monthly positivity

Monthly Avg Positive/Negative Close

Positive Count
Negative Count
Average Positive %
Average Negative %

Frequently Asked Questions

What is the current Smith & Nephew PLC (SN) stock price?

SN last closed at 1,127.00 $ (Jul 3, 26). Price data is refreshed after every trading day.

What is the P/E ratio of SN?

Smith & Nephew PLC trades at a trailing-twelve-month P/E of 20.56. See the comparison tables on the Peers tab for the industry context.

What is the market capitalization of Smith & Nephew PLC?

Smith & Nephew PLC (SN) has a market capitalization of approximately 13.1 B $ as of the latest reported period.

Who are the main competitors of SN?

Key peers of Smith & Nephew PLC include Inogen Inc, QuantumSi Inc, Quanterix Corp, CVRx Inc, InfuSystems Holdings Inc. A detailed metric comparison is available on the Peers tab.

Go deeper on SN

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.